Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

Abstract Background Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients at risk for progressive pulmonary fibrosis. This study investigates autoantibodies measured in bronchoalveola...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Viggo Hamberg, Azita Sohrabian, Elizabeth R. Volkmann, Marie Wildt, Anna Löfdahl, Dirk M. Wuttge, Roger Hesselstrand, Göran Dellgren, Gunilla Westergren-Thorsson, Johan Rönnelid, Kristofer Andréasson
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2023-09-01
סדרה:	Arthritis Research & Therapy
נושאים:	Systemic sclerosis Interstitial lung disease Ro52 Autoantibody Biomarker
גישה מקוונת:	https://doi.org/10.1186/s13075-023-03141-4
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!